Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability.

This publication has 78 references indexed in Scilit:

• Is planar thallium-201/fluorine-18 fluorodeoxyglucose imaging a reasonable clinical alternative to positron emission tomographic myocardial viability scanning?
  European Journal of Nuclear Medicine and Molecular Imaging, 1995
• Relation between myocardial uptake of thallium-201 chloride and fluorine-18 fluorodeoxyglucose imaged with single-photon emission tomography in normal individuals
  European Journal of Nuclear Medicine and Molecular Imaging, 1995
• Myocardial viability: Fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization
  American Heart Journal, 1994
• Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction
  The American Journal of Cardiology, 1994
• Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting
  The American Journal of Cardiology, 1989
• Reversibility of Cardiac Wall-Motion Abnormalities Predicted by Positron Tomography
  New England Journal of Medicine, 1986
• A Randomized Trial of Coronary Artery Bypass Surgery
  New England Journal of Medicine, 1985
• Results of coronary artery surgery in patients with poor left ventricular function (CASS).
  Circulation, 1983
• Survival of medically treated patients in the coronary artery surgery study (CASS) registry.
  Circulation, 1982
• Clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS).
  Circulation, 1981